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Abstract
Early evaluation of new drug entities for their potential to cause mitochondrial dysfunction is becoming an important task
for drug development. Multi-parametric high-content screening (mp-HCS) of mitochondrial toxicity holds promise as a lead
in-vitro strategy for drug testing and safety evaluations. In this study, we have developed a mp-HCS and multi-parametric
data analysis scheme for assessing cell responses to induced mitochondrial perturbation. The mp-HCS measurements are
shown to be robust enough to allow for quantitative comparison of biological systems with different metabolic pathways
simulated by alteration of growth media. Substitution of medium glucose for galactose sensitized cells to drug action and
revealed novel response parameters. Each compound was quantitatively characterized according to induced phenotypic
changes of cell morphology and functionality measured by fluorescent biomarkers for mitochondrial activity, plasma
membrane permeability, and nuclear morphology. Descriptors of drug effects were established by generation of a SCRIT
(Specialized-Cell-Response-to-Induced-Toxicity) vector, consisting of normalized statistical measures of each parameter at
each dose and growth condition. The dimensionality of SCRIT vectors depends on the number of parameters chosen, which
in turn depends on the hypothesis being tested. Specifically, incorporation of three parameters of response into SCRIT
vectors enabled clustering of 84 training compounds with known pharmacological and toxicological activities according to
the degree of toxicity and mitochondrial involvement. Inclusion of 6 parameters enabled the resolution of more subtle
differences between compounds within a common therapeutic class; scoring enabled a ranking of statins in direct
agreement with clinical outcomes. Comparison of drug-induced changes required variations in glucose for separation of
mitochondrial dysfunction from other types of cytotoxicity. These results also demonstrate that the number of drugs in a
training set, the choice of parameters used in analysis, and statistical measures are fundamental for specific hypothesis
testing and assessment of quantitative phenotypic differences.
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Introduction
A growing number of diseases, including diabetes, cardiovas-
cular diseases, cancers and neurodegenerative processes have been
linked to mitochondrial dysfunction [1,2]. An emerging under-
standing of the roles of the mitochondria in the overall integration
of cellular signaling events motivates the creation of new methods
and tools to understand the behavior of systems in the context of
mitochondrial functions [3,4]. Additional meaningful insights
linking molecular changes to physiological effects motivate more
integrated approaches to understanding phenotypic fate of cells
and organs. Among these objectives is the use of in vitro higher
content phenotypic assays that have potential to shed insights on
the role of specific molecular events in all cell and population
response.
There are established arenas where mitochondrial dysfunctions
are important for recognition and quantification of early apoptotic
commitment. In particular, drug-induced damages to cardiac and
liver tissues are common causes of therapy related organ failures.
The primary side effects of various drugs have been attributed to
mitochondrial toxicity resulting in promising drugs being with-
drawn from the market [5]. Often, timely detection of undesired
toxicity enables the development of a safer therapy which can even
include considerations of pharmacological protection of sensitive
tissues [6]. An example of this approach is the use of Dexrazoxane
cardio-protection from anthracycline-induced toxicity [7]. Early-
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stage quantitative assessment of tissue-specific, drug-induced
mitochondrial toxicity is a clear need for drug development and
safety pharmacology. However, there continues to be a deficiency
in the platform-independent metrics to classify all drugs for
potential clinical risk.
The mitochondrial membrane potential (MMP) is critical in
maintaining the driving force for oxidative-phosphorylation and
ATP synthesis through ADP phosphorylation by mitochondrial
ATP synthase (complex V). Changes in MMP often reflect
mitochondrial activity and cellular commitment to apoptosis. In
response to pro-apoptotic signaling factors or ROS generation,
mitochondrial membrane permeability changes, causing the
characteristic drop in MMP and further release of pro-apoptotic
factors [8]. In addition to the intrinsic apoptotic pathway, other
processes impact the MMP including necrotic cell death and non-
apoptotic mitochondrial uncoupling. Whether MMP loss is an
instrumental step of the apoptotic pathway, an epi-phenomenon of
cell death, or a manifestation of other mitochondrial mechanisms
often remains inconclusive. There are several general mechanisms
associated with known drug-induced MMP changes, including (i)
inhibition of mitochondrial complexes I-V and ANT (adenosine
nuclear transferase), (ii) mitochondrial uncoupling, (iii) activation
of pro-apoptotic signal transduction pathways that lead to the
formation of mitochondrial membrane permeability pores, and (iv)
induction of non-mitochondrial cell death accompanied by a drop
in MMP at a late stage [5,9]. Distinguishing between these or
other molecular mechanisms is a highly significant but challenging
problem which solution will enable to predict clinical risk of new
or investigational drugs.
Cellular regulation of mitochondria-mediated ATP generation
and apoptosis, along with glycolytic ATP generation enables cells
to cope with various nutrition environments and manage diverse
energy demands. Substitution of galactose for glucose in the cell
culture medium proved to inhibit or significantly downregulate net
cytoplasmic ATP production and leave mitochondrial oxidative
phosporylation as a major mechanism of ATP synthesis, thus
sensitizing cells to mitochondrial abnormalities [10,11]. Evaluation
of mitochondrial dysfunctions using comparative drug effects
between glucose and galactose carbohydrate sources in cell culture
medium of HepG2 and H9c2 cells demonstrated sensitization of
galactose-feed cells to mitochondrial toxicants [4,12]. However,
the analysis of cell response under different medium conditions
was limited to the visual comparison of dose-response curves or
comparison of IC50s, rendering it a system with limited content.
Development of robust multi-parametric high content screen
(mp-HCS) which enables automated assessment of mitochondrial
perturbations based on the differential cell responses to com-
pounds in two different growth conditions is a new approach. We
implemented imaging cytometry techniques to simultaneously
monitor several parameters extracted from quantitative analysis of
biomarker intensity and distribution, including MMP (TMRM),
plasma membrane permeability (TO-PRO-3), and nuclear mor-
phology (Hoechst33342), as functions of compound concentration
and medium carbohydrate content. A training library of 84
compounds was assembled to include compounds with variable
degrees of chemical similarity and expected mechanisms of action,
including mitochondrial respiratory chain inhibitors, oxidative
stress inducers, DNA disrupting agents, and kinase inhibitors. The
basis of our differential mitochondrial toxicity mp-HCS is the
assumption that drug-induced activation of pro-apoptotic signaling
will not be affected by the decrease of glycolytic ATP. However,
drugs that cause direct perturbations to mitochondrial machinery
will have detrimental effects on cellular viability under conditions
when glycolysis is not available. Simultaneous analysis of multiple
cellular features at identical compound doses but in different
culturing conditions provided data to develop a schema for
automatic separation of mechanistic classes through the applica-
tion of multivariate analysis (multiparametric image cytometry).
Common approaches for evaluation of multiparametric re-
sponse in HCS and cytometry involve identification of the earliest
responsive parameter [4,13,14,15], and correlation analysis of
measured parameters with or without factor analysis [16,17,18]. A
hypothesis-driven selection of conditions, parameters, and statis-
tical distance measurements was pursued as an approach toward
mining of information-rich data sets. Specifically, a data-driven
statistical model for assessing differential responses to induced
mitochondrial toxicity has been developed. The essence of
differential response analysis is that in addition to characterization
of cell response to a compound, the change of cell responses as a
function of environmental conditions are analyzed leading in
essence to a multifactorial response dataset. The data reduction
involves the construction of an n-dimensional specialized cell
response to induced toxicity (SCRIT) vector consisting of a
number of normalized statistical measures of pre-defined param-
eters. A single SCRIT vector characterizing multi-parametric cell
response to compound action was composed for each drug.
Correlation analysis of SCRIT vectors enabled automatic
clustering of compounds into five predicted categories according
to the induced toxicity response: direct inhibition of mitochondrial
machinery, glucose-independent induction of pro-apoptotic sig-
naling, glucose-dependent toxicity, mitochondria uncoupling, and
no toxicity response. Moreover, an increase in the number of
parameters of cell response enabled further subdivision of
compounds into more narrow clusters to appreciate fine differ-
ences in phenotypic cellular response to a specific compound.
Results
Assay development and parameter definitions
The experimental design involves comparative analysis of
differential drug effects in two biological settings with ultimate
normalization to controls. This requirement places demands on
understanding experimental sources and precision in estimates of
error. Briefly, assay development included optimization of the
seeding cell density to achieve maximal cell count and accurate
Hoechst33342–based nuclear segmentation using the iCys soft-
ware, 48 h after plating. A seeding concentration of 46104 cells/
well was established to be optimal for HepG2 cells under in-house
culturing conditions (see Materials and Methods and Methods S1).
Cells were seeded 18 h to 24 h before the addition of compounds.
After 24 h of cell exposure to a compound, the cell marker cocktail
was added to the medium for 45 min. Cultures were then
transferred to the iCys imaging cytometer for data collection. The
cell-permeable nuclear marker Hoechst33342 was used for nuclear
segmentation and cytoplasmic or peripheral area definition as well
as for nuclear morphology characterization. TMRM, a lipophilic
fluorescent cationic dye marker, was used to monitor MMP
changes [19]. TO-PRO-3 membrane-impermeable nuclear mark-
er was used to characterize plasma membrane integrity and,
hence, cell viability.
The protonophore FCCP (protonophore trifluoromethoxy
carbonyl cyanide phenylhydrazone) was chosen as the end-point
control for assay optimization for both MMP change (TMRM
signal decrease) and cell death (TO-PRO-3 signal increase). This
compound renders the mitochondrial membrane permeable to
protons and results in immediate MMP dissipation and uncou-
pling of oxidative phosphorylation from ATP synthesis. Assay
parameters and conditions were established and experimental
Differential Screen Multi-Parametric Data Analysis
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error was estimated using multiple repeats of untreated and
FCCP-treated samples. Specifically, assay development utilized a
96-well plate containing 6 columns treated with 75 mM FCCP (48
FCCP-treated samples) and 6 columns treated with 0.2% DMSO
(48 untreated samples) for 24 hours. The plates were used for (1)
definition of statistical measure of parameters, (2) well-to-well
variability calculation, and (3) estimation of Z9 showing separation
between positive and negative controls, (4) variability between
multiparametric vectors assessed using correlation analysis.
Typical fields of view for untreated and FCCP-treated cells are
shown in Figure 1A. FCCP-treated cells exhibit dramatic change
of cellular morphology: cells become round and retain no
cytoplasmic spreading, based upon manual examination of light-
scatter images. Changes in nuclear morphology are equally
drastic, with nuclei becoming rounded and reduced in size, with
condensed nuclear material (Hoechst33342 channel). Dissipation
of MMP is visualized by the loss of cytoplasmic, perinuclear,
mitochondria-specific TMRM distribution. Finally, FCCP-treated
cells contained two cell populations, TO-PRO-3-positive and TO-
PRO-3-negative. A population of TO-PRO-3-positive cells
corresponds to late apoptotic or necrotic cells (TO-PRO-3
channel), while a population of TO-PRO-3 negative cells
represents cells either at early stage of apoptosis or cells with
uncoupled (inactive) mitochondria since mitochondrial uncoupling
by FCCP does not necessarily lead to apoptosis [20].
To quantify cell responses to FCCP, seven measured param-
eters were analyzed and compared between treated and untreated
populations. Histograms of the population distribution of selected
parameters are shown in Figure 2. A small but significant
(p%0.05) difference between arithmetic means was demonstrated
for normally distributed parameters. The bar graphs (Figure 2A,
left inserts) demonstrate mean and standard deviation calculated
based on 48 FCCP-treated and 48 untreated samples. However,
for non-normal distributions, and moreover, bi-modal distribu-
tions of responses, Kolmogorov-Smirnov (KS) distance was
implemented as a dissimilarity measure normalized against the
in-plate untreated controls. KS distance has been previously used
for measuring dissimilarity of distributions in high-content image
data analysis [15,16]. In this study, this distance is defined as the
maximum signed difference between cumulative distribution
functions (CPFs) which were built for each of the 48 FCCP-
treated samples and the 48 untreated controls. Four representative
cumulative probability functions are plotted independently for
each parameter for both treated and untreated conditions to
demonstrate the high robustness (Figure 2A right); KS mean
values and standard deviations are plotted as a bar graph
(Figure 2A, right inserts).
The type of distributions of values measured for individual
parameters are in principle unknown. For this reason, each
parameter was individually analyzed and the best statistical
measure representing dissimilarity between populations was
selected. While gradual concentration-dependent changes of
TMRM and Hoechst33342 intensity represent the biological
measure of MMP and nuclear changes, for TO-PRO-3 only the
end-point responses meaningfully reflect the plasma membrane
status. An empirical gating approach to quantify TO-PRO-3-
positive and -negative cell populations was employed (Figure 2B,
left graph); the statistical measure of viability represents a percent
of positive cells (viability factor). A bar graph demonstrates the
mean viability with standard deviation calculated based on 48
untreated and 48 FCCP-treated samples (Figure 2B left graph,
insert). Note that about 50% of FCCP-treated cells remain viable
(or TO-PRO-3-negative). The CDF of TO-PRO-3 mean intensity
(Figure 2B, left graph) reflects the bimodal nature of the TO-PRO-
3 distribution and demonstrates high variability when KS distance
is used (Figure 2B, left graph insert). The TO-PRO-3 empirical
gating values were determined for each plate according to visual
examination of TO-PRO-3 distribution. For all analyzed plates,
empirical TO-PRO-3 gating values were between 1.86103 and
2.56103. Figure 2B summarizes the behavior of dissimilarity
measures for 7 parameters, including 2 measures of TO-PRO-3
response for comparison (KS and percent viability). The modified
box-and-whisker graphs demonstrate confidence intervals of the
mean and standard deviation for different measures of response
(Figure 2C).
A single parameter (with the exception of nuclear area) proved
to be sufficient to distinguish between untreated and FCCP-treated
populations based on Wilk’s lambda test (data not shown).
However, in order to distinguish other phenotypic categories
more than one image-based parameter must be included. For
example, two parameters characterizing MMP (KS of TMRM
peripheral integral intensity) and viability (% of TO-PRO-3-
negative cells) enabled us to distinguish 4 visually appreciated
phenotypic categories: (1) no change of MMP and viability, (2)
partial response, as MMP decrease with partial loss of viability, (3)
complete response, as MMP and viability drop, and (4) unexpected
response, as MMP increase but viability decrease (Figure 1).
To differentiate the cellular responses to FCCP, chelerythrine,
nicardipine, and DMSO under two environmental conditions,
TMRM KS and viability were sufficient parameters for quanti-
fication of these treatments (Figure 1B–E). Treatment with FCCP
resulted in a drop in MMP accompanied by some decrease in
viability. In contrast, treatment with chelerythrine, a potent
protein kinase C inhibitor, resulted in 100% MMP and viability
loss. Nicardipine, a calcium-channel blocking agent, at high
concentration (100 mM) caused a surprising increase of TMRM,
accompanied by a decrease in cell viability. Image analysis
revealed no increase in background TMRM channel fluorescence,
whereas cell-associated TMRM staining was greatly increased
even for TO-PRO-3-positive cells (Figure 1A). A graph of CPFs
for TMRM intensity reflects the visually-appreciated TMRM
signal increase for nicardipine as a shift to the right from the
DMSO-treated control sample (Figure 1B, blue line) and positive
sign of KS value (Figure 1D–E), while FCCP- and chelerythrine-
induced TMRM decrease is reflected by a left shift of CPFs
(Figure 1B, red and green lines) and negative sign of KS value
(Figure 1D–E).
Differential dose response and SCRIT vector construction
After the end-point assay optimization and parameter defini-
tion, analysis of 10-point dose-response screens executed in
quadruplicate for known mitochondria toxicants FCCP, ionomy-
cin, rotenone, and antimycin A was performed. FCCP-treated
cells exhibited gradual loss of MMP accompanied by a similar
decrease in viability (Figure S3A, first and second graphs).
Interestingly, strong mitochondrial respiratory complexes inhibi-
tors rotenone and antimycin A demonstrated modest or no effect
on MMP and viability, respectively (Figure S3A, left two graphs).
The same compounds were analyzed in glucose-free (glu2)
medium conditions, applying a nutrient-sensitization strategy to
shift cellular metabolism from cytoplasmic glycolysis to mitochon-
drial oxidative phosphorylation [10]. HepG2 cultures grown in
medium with galactose as the major carbohydrate source
demonstrated increased sensitivity to mitochondrial toxins, espe-
cially to inhibitors of oxidative phosphorylation machinery
(Figure 3A, right two graphs). MMP and cell viability of cells
treated with rotenone and antimycin A showed significant
decreases after substitution of galactose for glucose. The TMRM
Differential Screen Multi-Parametric Data Analysis
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dose response to FCCP demonstrated little or no change with a
striking decrease in viability. Intriguingly, dose responses of
ionomycin did not change in different culturing media.
The variation in cell responses to compound treatments
depending on glucose availability is best illustrated when two
parameters, TMRM KS based upon peripheral integral signal (PI)
and the viability index, for two nutrient conditions (glu+ and glu2
media) are plotted (Figure S3B). Antimycin A and rotenone are
characterized by a similar trend of responses as a dramatic
decrease of both TMRM and viability in glu2 conditions. Cell
response to ionomycin reflects no change of toxicity between glu+
and glu2 conditions. A completely different pattern of cell
response to FCCP is revealed by a change in viability along with
little change in TMRM. Heat-map representation of dose
response for KS values of TMRM signal and viability indexes
for glu+ and glu2 media conditions (Figure S3C) enabled more
compact data visualization. Differential multi-parametric cell
responses to a specific compound are referred to as specialized-
cell response-to-induced-toxicity (SCRIT) vectors. In this example,
40-point SCRIT vectors were constructed from two parameters of
cell response (MMP PI and cell viability), 10 concentrations (from
0.005 mM to 100 mM), and two nutrient medium conditions (glu+
and glu2) for each repeat of each compound. Other parameters
Figure 1. Examples of HepG2 response to treatment with different compounds with various types of quantitative analysis and data
representation. Hoechst33342, TO-PRO-3, and TMRM were used to characterize the untreated HepG2 population and the cell toxicity response
induced by different compounds. Cells were seeded at the same time and density, incubated for 24 h with 100 mM of different compounds, stained
with a cell marker cocktail, and analyzed using an iCys imaging cytometer. A. Representative images (5006368 mm) demonstrate fluorescent signal
distribution for individual channels. A merged color image representing a combination of channels (TMRM-red, Hoechst33342-blue, TO-PRO-3-
magenta) is shown to demonstrate co-localization. A light-scatter image is shown to realize cell morphology. B. Cumulative probability functions
demonstrate TMRM change induced by different treatments: FCCP - red line, chelerythrine – green line, nicardipine – blue line, and untreated (DMSO)
- black line. C. Bar graph represents the fraction of viable (TO-PRO-3-negative) cells (black), and the fraction of dead (TO-PRO-3-positive) cells
(shaded). D. The bar graph represents responses of two parameters, TMRM KS values (solid bars) and the fraction of viable cells (shaded), to various
treatments. E. Color-coded representation of 2-parameter response for each of four compounds. Viability is rescaled from21 (all dead) to +1 (all live)
to match the range for KS values.
doi:10.1371/journal.pone.0045226.g001
Differential Screen Multi-Parametric Data Analysis
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defined in Figure 2 were added to SCRIT vectors when necessary
for a specific analysis.
Primary screening and compound selection
We performed a pre-screening using a single high dose
(100 mM) of each drug from a library of 74 (excluding 10 control
toxicants). Plate layout for this screen is displayed in the
Supporting Information (Figure S4). Briefly, the last column of a
96-well plate contained four positive controls (FCCP at 75 mM)
and four DMSO-treated negative controls; other wells were
treated with different compounds. Duplicate plates for each
carbohydrate condition (glu+ and glu2) were prepared. Images
were visually analyzed for toxicity response and staining abnor-
malities after 24 h incubation of cells with compounds. Euclidean
distance was used for multidimensional scaling and hierarchical
clustering to visualize and exam SCRIT vectors in order to select
responsive compounds for secondary screening. Non-active
compounds were designated as group IV compounds (Table S1).
Figure 2. Definition and selection of statistical measure of parameters. Forty-eight FCCP-treated and 48 non-treated (DMSO) samples were
used for statistical analysis of population variability. Seven iCys output parameters were selected for the analysis: TMRM peripheral integral and max
pixel intensity, Hoechst33342 integral and mean intensity, nuclear area and circularity, and TO-PRO-3 mean intensity. A. Right panel shows
histograms of parameter distribution for untreated (red) and FCCP-treated (blue) samples. Insert bar graphs demonstrates mean values with standard
deviation for all parameters. The left panel shows the corresponding cumulative probability functions (CPFs), which are the basis for the Kolmogorov-
Smirnov (KS) value calculation. Representative four repeats of untreated (blue lines) and four repeats of FCCP-treated (red lines) samples are
individually plotted to demonstrate the deviation and robustness of each parameter. Insert bar graph demonstrates mean KS values with standard
deviation calculated using averaged untreated population. B. Right panel shows histograms of parameter distribution for untreated (red) and FCCP-
treated (blue) samples. An empirical gating value (punctuate line) was used to quantify the number of TO-PRO-3-positive cells; and % live (TO-PRO-3-
negative) cells is plotted in the insert. The left panel shows the corresponding CPFs for four representative repeats of untreated (blue lines) and FCCP-
treated (red lines) samples. Insert bar graph demonstrates mean KS values with standard deviation calculated using averaged untreated population.
C. Modified box-and-whiskers graph demonstrates comparative behavior of 8 statistical measures: 7 parameters as KS values and a TO-PRO-3-derived
viability index in %. Boxes correspond to 95% confidence interval of the mean calculated based on 48 repeats (black circles - mean values for
untreated; black triangles - for FCCP-treated populations). Standard deviation of the mean is also shown. Red - TMRM peripheral integral intensity,
green - max pixel intensity, dark blue - Hoechst33342 integral intensity, blue - mean intensity, magenta - nuclear area, yellow - nuclear circularity, dark
purple - TO-PRO-3 mean intensity, light purple - viability in %.
doi:10.1371/journal.pone.0045226.g002
Differential Screen Multi-Parametric Data Analysis
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In the primary screens, an arbitrary cut-off of 20% change in any
of the seven values composing SCRIT vectors was used to select
active compounds. This cut-off value is safely above coefficients of
variation for the repeated controls. The entire process was
manually verified by inspection of morphological changes visible
in transmitted light iCys images; selection of compounds like
Nilutamide which was incorrectly assigned to Group IV on the
primary screen were identified. Several compounds were found to
be incompatible with the live-cell-no-wash protocol and automat-
ed LSC analysis due to autofluorescence or interference with
Hoechst33342 nuclear staining and impairment of nuclear
segmentation (Figure S5). These compounds were removed from
the subsequent automated analysis but the data obtained are
available for visual examination and interpretation.
Automated SCRIT analysis and compound clustering
Secondary screening was performed using the pre-selected set of
53 compounds, which included a group of well-characterized
mitochondrial toxins, a group of compounds that demonstrated
phenotypes of response in primary screening, and chemical or
pharmacological analogs of responsive compounds. Data from 10-
point dose response experiments were collected in duplicate or
quadruplicate and SCRIT vectors were built for each repeat
independently using data from both medium conditions. The final
96-well plate layout for the secondary (dose response) screening
contained two repeats of ten, 1:3 dilutions of each compound,
along with eight positive (treated with 75 mM FCCP), and eight
negative (DMSO-treated) controls.
Further data reduction was performed by multidimensional
scaling (MDS) and hierarchical clustering of SCRIT vectors for
each of the 10 step dose replicates in two medium conditions.
Abbreviated SCRIT vectors based upon three parameters with
Figure 3. Correlation analysis of SCRIT vectors. Correlation analysis was performed using pair-wise Pierson distances of SCRIT vectors. A.
Dendogram of hierarchical clustering of SCRIT vectors in the 40-dimensional parameter space incorporating glu+ and glu2 data points. Color scale is
shown on the right. B. 3D plot of MDS of SCRIT vector correlation analysis. C. 2D plot of MDS of SCRIT vector correlation analysis: I - direct
mitochondrial toxins, II - glu-independent toxins, III - glu-dependent toxins, IV - non-toxic or inactive compounds, and V - uncoupling compounds
such as FCCP.
doi:10.1371/journal.pone.0045226.g003
Differential Screen Multi-Parametric Data Analysis
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highest discriminatory power derived from individual cellular
markers were used: KS distance between distributions of TMRM
PI, KS distance between Hoechst33342 mean cell intensity, and
percentage of viable cells or viability (Figure 3). For the purpose of
multidimensional scaling and hierarchical clustering, the similarity
(distance) between compounds was defined as Pearson distance
between SCRIT vectors. The dendrogram in Figure 3A reflects
groups of compounds with similar biological responses; smaller
distances reflect larger similarity between compounds. Replicates
of each compound were analyzed independently and the
corresponding replicate data formed the clusters with the smallest
pair-wise comparison distances, demonstrating consistent repro-
ducibility of the assay and analysis (dissimilarity less than 0.2).
Compounds which demonstrated high pair-wise dissimilarity of
their repeats (.0.2) were removed from analysis as outliers, for
example amitriptylene and haloperidol. Multidimensional scaling
was performed to visualize the similarities between different
compounds (Figure 3B, C) in two dimensional formats. Mito-
chondrial toxins with direct action such as antimycin A,
oligomycin, valinomycin, and rotenone formed one well-defined
cluster I (Figure 3, orange). This cluster is marked as I on the
clustering dendrogram and 2D graph of MDS analysis. Dramatic
decreases in MMP and viability and increase in nuclear intensity
are characteristics for compounds in this cluster. Valinomycin is
assigned to cluster I despite no change in TMRM behavior
between glu2 and glu+ conditions possibly because its dose
response is not complete due to MMP dissipation even at the
lowest tested concentration (5 nM).
Compounds in cluster II (Figure 3, blue) displayed significant
cytotoxicity in glucose-independent fashions. Another group
(cluster III) includes compounds that demonstrate mitochondrial
perturbations only under the sensitizing conditions with prominent
changes of parameters after glucose withdrawal (Figure 3, yellow).
A large group of non-toxic or inactive compounds are combined in
cluster IV (Figure 3, red). Several small groups include (a) a cluster
of FCCP repeats that demonstrate a dramatic change in viability
with little or no change in TMRM dose response upon glucose
withdrawal; (b) a cluster formed by nicardipine, which caused a
spectacular increase in TMRM along with a drop in viability in
both medium conditions; (c) bortezomib, bafilomycin A, terfena-
dine, and chelerythrine demonstrated a similar response in both
conditions and hence could be assigned to group II (Figure 3B,
punctuate line). The terfenadine SCRIT revealed an artifact in
TO-PRO-3-positive cells at the highest concentration; manual
examination of images ultimately re-assigned this compound to
group II.
Discussion
Sensitivity to a compound in the in-vitro cell-culture model is a
capricious parameter because it depends on many experimental
parameters, including passage number, quality of plastic coating,
trypsinization procedure, and is sensitive to subtle variations of
experimental conditions such as extent of cells adhesion,
compound incubation time, or temperature modulations. For
example, 24 h of HepG2 incubation with 75 mM FCCP routinely
resulted in the presence of a subpopulation of viable cells with
greatly decreased MMP. However, this population is sensitive to
incubation conditions and might disappear through prolonged
exposure to room temperature during scanning. Our results
demonstrate feasibility for development of a robust experimental
platform to assess compound effects on populations of live cells,
and feasibility for creation of a statistical model. Using a set of
biomarkers to characterize mitochondrial activity and cell
viability, we were able to distinguish between different types of
mitochondrial involvement in the response to 84 tested com-
pounds acting via diverse modes. Comparison of changes of dose
response collected at uniform conditions decreases the possibility
of misleading representation of a single-dose response shift. Cell-
population dose responses in different medium conditions were
incorporated into a single multi-parametric analysis culminating in
semi-automated clustering of drugs.
Parameters such as total, average, or maximal cell marker
intensity per cell and area were computed from measured marker
fluorescence. The best dissmilarity measure among mean,
medium, percent of gated cells, or KS distance between
populations was selected for each parameter individually based
on the Z9 value calculated for populations of cells treated with
FCCP (positive control). The KS distance was established to be the
best measure for parameters derived from Hoechst33342 and
TMRM in terms of Z9-expressed separation between positive and
negative controls, in-plate normalization against untreated control,
and uniformity of normalization between different parameters. For
TO-PRO-3-derived descriptors the percent of live cells proved to
be a better quantitative measure since only the binary ‘‘yes’’ or
‘‘no’’ response was meaningful while gradual changes of TO-
PRO-3 were irrelevant for current study. Hoechst33342 is a
membrane-permeable nuclear marker whose intensity depends on
the nuclear content of the cell; membrane-impermeable TO-
PRO-3 is the measure of membrane permeability, and its
functional dependence on nuclear content is not well established.
The use of KS distance as a dissimilarity measure of image-based
biological assays has been previously demonstrated [16]. If other
descriptors are added to the analysis, the respective dissimilarity
measures should be selected by taking into consideration,
distributions of responses and a priori knowledge of cell marker
targets. This approach enables construction of response vectors
incorporating different measures of dissimilarity for individual
cellular responses; a more comprehensive summary descriptor is
the result.
A strategy to increase the dimensionality (feature space) to
reflect environmental influences on drug action is enabled by the
use of different growth conditions. Analysis of dose response curves
has become common practice in high-content analysis because it
provides a dynamic function of response to drug concentration
[21]. However, comparison of dose responses between different
environmental conditions is an under-evaluated approach [22].
This N61062-dimensions multifactorial response dataset was
scaled, control-normalized and finally vectorized to create SCRIT
vectors. Besides the increase in feature space, a major advantage of
this approach is that differing cell sensitivity to individual
compounds is standardized; the analysis compares sensitivities at
two different conditions, rather than employing an absolute value
of the responses.
The key advantages of the differential cell-response and
unsupervised classification platform are: (a) robustness, (b)
amenability to automation, and (c) uniformity between parameters
and d) potential platform independence. Moreover, the differential
screen comparing responses in two environments reduces the
impact of incubation time and concentrations on the classification
outcome. The absence of pre-conceived parametric model for dose
responses also reduces the influences of aberrant effects caused for
example by high compound concentrations or iCys incubation
times during the data acquisition.
A major problem encountered for the classification assay is the
undesired compound-marker interactions occurring for some of
the tested chemicals. This is an important but not well recognized
problem for all HCS, but specifically for live-cell analysis, which
Differential Screen Multi-Parametric Data Analysis
PLOS ONE | www.plosone.org 7 October 2012 | Volume 7 | Issue 10 | e45226
preferentially uses ‘‘add-in’’ protocols where compounds are
present in medium at time of analysis [23]. Two important causes
of possible false responses are compound autofluorescence and
compound interference with the cell marker dyes [24]. Compound
autofluorescence can overlap with the emission spectrum of a
particular cellular marker and mask or alter the signal; compound
emission spectra overlap with Hoechst33342 impedes proper
image segmentation. Therefore, a pre-screen image analysis
protocol was employed to identify possible interferences with
normal marker fluorescence.
The proper choice of image features (extracted cellular
parameters) for HCS experiments is a complex image-processing
and pattern-recognition problem. Usually the process relies on
expertise of investigators or uses algorithms for data-reduction and
selection [15,18]. The approach presented here used a hypothesis-
testing rationale where the selection of measured parameters was
based on cellular functions assumed to be affected by the
compounds.
Monitoring of MMP and cellular viability under conditions of
varied glucose content are especially important since glucose
withdrawal sensitizes cells to mitochondrial abnormalities [10,11].
MMP changes may not necessarily be an initial committed step of
apoptosis, but may accompany necrotic cell death or even reflect
mitochondrial uncoupling. Decrease of cell viability after glucose
withdrawal delineates the mitochondrial component of the
compound-induced toxicity as the cytoplasmic glycolytic alterna-
tive of ATP generation is abolished. In normal medium, inhibition
of mitochondrial functions by a compound may be compensated
for, and masked by cytoplasmic glycolysis, but revealed under
reduced glucose conditions. At the same time, independence of
compound action from glucose availability suggests activation of
apoptotic signaling pathways that are not compensated by
glycolysis.
For the mp-HCS developed here, the employed measure of
inter-compound distance can be potentially used to automatically
identify similarities between newly tested compounds and the
previously tested substances. The broader question addressed in
the current study is whether a semi-automated imaging platform
can be used to classify MMP-affecting compounds into functional
classes: direct inhibitors of mitochondrial complexes, general
modulators of mitochondrial function, direct inducers of intrinsic
apoptotic pathways, or caused no phenotypic changes.
The demonstration of careful selection of image features (cell
parameters), as well as normalization and vectorization of
multifactorial responses, enabled clustering of tested compounds
into groups associated with mechanism(s) of mitochondrial
perturbation. The constructed SCRIT vectors were used to build
hierarchical response classes, and were employed to perform MDS
enabling visualization of compound classes in the reduced space of
biological responses. For example, direct mitochondrial toxicants
like rotenone and antimycin A were all attributed to the well-
defined separated cluster (group I) when differential dose response
and 60-dimensional SCRIT vectors were utilized. For comparison,
a similar analysis was performed using SCRIT vectors that
included only data collected in glucose-rich conditions, without the
effect of glucose depletion (Figure 4A). The well isolated cluster of
direct mitochondrial toxicants was lost and compounds like
antimycin A, oligomycin, valinomycin, and rotenone were
separated into different clusters (Figure 3A) when unifactorial
data were processed..
Compounds like ionomycin formed another well-defined cluster
(group II) that combines compounds whose toxicities are not
compensated by glucose medium. This group may either activate
mitochondria-independent death pathways with accompanying
epi-phenomenal MMP decrease or induce mitochondria perme-
ability transition independently of glycolysis. Group III are
compounds that impact mitochondria function only under
conditions of glucose limitation. Indeed, glucose withdrawal
resulted in the decrease of cell viability accompanied by MMP
decrease. Compounds like tacrine and nilutamide also display such
behavior while clustered to group IV.
A cluster of compounds showing minimal or non-toxic
responses in both conditions are largely approved drugs in group
IV. A potential caveat is that these compounds may require
metabolic activation by specific enzymes that are not expressed in
HepG2 cultures. Conversely, some of these compounds can be
enzymatically deactivated by HepG2 cells. These pharmacokinetic
features are not included in the model at this point. A future
application of the SCRIT-based differential response screen could
be comparison of the differential effects of compounds with and
without activation of specific cytochrome P450 (CYP) enzymes. A
second cell model selected for known enzymatic expression
patterns would be a likely approach to further distinguish the
drugs in this cluster.
FCCP represents compounds with the potential to uncouple
mitochondria oxidative-phosphorylation from ATP synthesis, and
the cell could potentially survive through glycolysis (group V). The
distinction from group II is based upon change of viability with no
effect on TMRM. FCCP is largely not associated with a general
toxic effect on cell viability and argues that it represents a unique
mechanistic class [20].
Other image features can be extracted from the collected data
and added to analysis by increasing the length of the SCRIT
vector. An advantage is that more detailed information on fine
differences between drugs within a therapeutic class can be
derived. For example, out of three tested statins (HMG-Co A
reductase inhibitors), simvastatin was clustered into group III
based upon glucose-independent phenotypic responses at high
concentration while pravastatin and fluvastatin were clustered
together into group IV. When three more parameters were added
to the SCRIT vectors, fine differences in cell responses to
pravastatin and fluvastatin were revealed (Figure 4B). Even though
the increase in TMRM intensity induced by fluvastatin over
pravastatin is noticeable by visual examination of images
(Figure 4B, top panel), TMRM peripheral integral signal intensity
(Parameter 1 on Figure 4B) did not change. On the other hand,
the maximal value of intensities associated with TMRM (‘‘max
pixel’’ parameter in iCys) increased dramatically in cases of
simvastatin and fluvastatin but not pravastatin. TMRM maximal
pixel parameter reflect MMP increases might occur due to
alterations of cytoplasmic morphology from decreased cell
adhesion and spreading, leading to higher cytoplasmic density in
proximity to the nucleus. When TMRM maximum pixel intensity
was analyzed, the increase in fluvastatin-treated over pravastatin-
treated cells was also apparent (Parameter 4 on Figure 4B). The
differential toxicities of statins in a variety of assays has been
demonstrated; the more hydrophilic pravastatin is minimal, while
lipophilic statins, including simvastatin and fluvastatin, are known
to reduce hepatocyte viability and impair skeletal muscle
mitochondria [25,26,27,28]. Using these additional features
reveals that fluvastatin is closer to simvastatin then to pravastatin
(Figure 4B) in the space of biological responses.
This example of defining a quantitative metric for differential
mitochondrial toxicity using a semi-automated data analysis
provides a new tool set for assessing chemical effects on biological
systems. The schematic outline for screening and analysis using the
overall approach can be generalized by the work-flow shown in
Figure 5. As presented, the example of mp-HCS using differential
Differential Screen Multi-Parametric Data Analysis
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phenotypes highlights a novel experimental and computational
approach for describing drug effects based upon analysis of
dissimilarities between normalized response vectors. By computing
a pair-wise distances between compounds on the basis of their
SCRIT, our analysis possesses a capacity to associate unknown
compounds with known mechanisms of action. The current
unsupervised classification schema assumes realistic changes of the
values of selected parameters using dose and glucose content as
factors. Further subdivision of classes could be created by
incorporating additional parameters (features) or conditions
(factors). Integration of additional features is shown to be useful
in distinguishing among drugs of a similar therapeutic class.
Moving this process forward toward the challenge of predictive in
vitro models appears increasingly feasible. These experimental and
computational approaches will serve as starting points to address
methodologies for drug dosing and/or development of safer
practices with pharmacotherapies.
Materials and Methods
Cell culture and reagents
All fluorescent biomarkers and cell culture reagents were
obtained from Invitrogen (Carlsbad, CA), D-galactose was from
Sigma. Chemicals were obtained from different sources as listed in
Table S1. The HepG2 human hepatocyte cell line was purchased
from ATCC (Manassas, VA) and cultures were maintained in a
humidified incubator under 5% CO2 at 37uC in MEM
supplemented with 10%FBS, l-Glutamax, and sodium pyruvate.
After attaining 90% confluence, cells were sub-cultured at 1:3
ratios following trypsinization with 0.25% trypsin/EDTA solution.
For glucose-free experiments, cells were maintained in glucose-free
MEM, supplemented with 10% glucose-free FBS, l-Glutamax,
sodium pyruvate, and 10 mM galactose. HepG2 cells were
maintained at passage number below 20.
Assay procedure
One day before the start of an experiment, cells were suspended
by trypsinization and immediately robotically seeded at a density
of 4.06105 cells/ml in 96-well collagen I–coated microplates (BD
Biosciences) using a Biomek 3000 Laboratory Automation
Workstation (Beckman Coulter) established in a tissue culture
hood. Cells were allowed to adhere for 18–24 h before compound
additions. For primary screening and secondary dose-response
experiments, compounds at specific concentrations were formatted
using a Biomek, added to plated cells, and incubated for 24 h at
37uC, 5% CO2.
Live cell marker stains
Following the incubation period, addition of dye markers was
performed with a staining procedure involving a cocktail of three
Figure 4. Examples of the effect of parameter addition or removal. A. Truncated SCRIT vectors containing only data collected in glu+
conditions demonstrate hierarchical clustering where direct mitochondrial toxicants oligomycin, antimicynA, rotenone, and valinomacin separated
into different clusters. B. Six parameters were used for the statin SCRIT vector formation to detect changes in cell response induced by individual
statins. Glu+ - glucose-containing medium, Glu2 - glucose-free medium, 1 – TMRM integral, 2 – Hoechst33342 mean 3 – viability, 4 – TMRM
maximum pixel, 5 – nuclear area, 6 – nuclear circularity. Arrow points to the TMRM max pixel dose response part of the SCRIT vector.
doi:10.1371/journal.pone.0045226.g004
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cell markers for the imaging cytometry analyses. The final
concentrations of dyes in each of the 96-wells were 125 nM
TMRM, 133 nM TO-PRO-3, 1.5 mg/ml Hoechst33342, and
20 mM verapamil (see Methods S1). After incubation of the cell-
containing plates for another 45 min at 37uC, 5% CO2, the cells
were immediately analyzed.
Data Collection
Ninety-six well plates were analyzed using an iCys Imaging
Cytometer (Compucyte, Corp.) configured with three excitation
lasers and four emission detector PMTs for blue, green, orange,
and near-infrared. Six fields-of-view (5006368.6 mm each) were
collected per well using a 206 objective at 0.5 mm resolution
(0.560.48 mm pixel size). TMRM was excited by the 488 nm Ar
laser and the emission recorded using PMT with 580/30 band-
pass filter, Hoechst 33342 was excited by a 405 nm diode laser
and emission recorded using PMT with 463/39 filter, and TO-
PRO-3 was excited by a 633 nm He/Ne laser and emission
recorded using PMT with 650 LP filter. The plate scanning
protocol was set to collect row well data in a z-manner where one
row is scanned after a row.
Data analysis
Image segmentation was performed using the iCys Cytometric
Analysis software (CompuCyte, Corp.). The protocol used single
primary contour to identify cell events, and a peripheral contour to
quantify cytoplasmic signal (Figure S1). The Hoechst33342
channel was used to find primary contours on a basis of adjacent
pixels above the preset threshold value (2500 a.u.). The primary
contours identify the presence of cells. The threshold value was set
once and maintained for the entire screen. Low pass 565
smoothing filter and watershed procedure were applied to separate
Figure 5. Schematic demonstration of high content screen and analysis. The screen algorithm is schematically represented the steps from
cell culturing to data collection and comprehensive data analysis. HepG2 cells were seeded on 96-well plates either in regular culturing medium
containing 5.5 mM glucose (glu+) or in glucose-depleted (glu2) medium containing10 mM galactose instead. Compounds were incubated for 24 h.
Multiple controls per plate allowed correction of systematic well-to-well changes during data analysis. After incubation for 45 min with cell markers
Hoechst33342, TMRM, and TO-PRO-3, plates were analyzed on the iCys. Six fields of view, each 500 mm6369 mm, were scanned per well with a single-
pixel resolution of 0.5 mm. The initial image analysis of nuclear segmentation and determination of primary peripheral interval (PI) for the cytoplasmic
signal was performed using iCys Cytometric Analysis software. Nuclear segmentation was performed according to the empirically-defined
Hoechst33342 intensity threshold value and maintained throughout the screening. Further data reduction included KS value calculation for each
parameter derived from TMRM and Hoechst33342 markers and per cent of viable cells derived from TO-PRO-3 using the empirical gating threshold
value for TO-PRO-3 intensity. All parameters were assembled in a SCRIT vector and subjected to dissimilarity metrics calculation with consecutive
correlation and MDS analysis.
doi:10.1371/journal.pone.0045226.g005
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closely spaced or overlapping nuclei. Additionally, an area filter/
discriminator was applied to eliminate clumps (max area 250 mm2)
and cell debris (min 20 mm2). For the purpose of intensity
integration, the primary contours were expanded by 4 pixels,
and the peripheral contours were set as a 14 pixels-width ring.
Unless otherwise stated, the parameter used for intensity of
TMRM was peripheral integral signal. In cases of extended
SCRIT, the TMRM maximal pixel intensity was used in addition.
After image feature extraction, further statistical analysis of
population distributions and graphical views were performed
using Matlab 7.12.0 (The MathWorks) and OriginPro 8 software
tools (OriginLab).
Testing of a 96-well plate with half of the wells treated with
75 mM FCCP (positive control) and half with 0.2% DMSO
(negative control) was used for (1) definition of statistical measure
of parameters, (2) well-to-well variability calculation, and (3) Z9
calculation for estimate of separation between positive and
negative controls, and (4) robustness of SCRIT definition and
computation of distances between SCRIT vectors.
(1) KS distances were established as dissimilarity measures for
TMRM- and Hoechst33342-based parameters, and percent-
age of live cells (viability factor) was established as a measure
of TOPRO-3-derived parameter. TO-PRO-3 average inten-
sity threshold values were 103.25 a.u. of intensity with the
exception of five plates that required threshold adjustments to
104 a.u.
(2) The selected statistical measures exhibited low level of intra-
plate and inter-plate variability. For instance, maximum pixel
TMRM KS distance between negative control and FCCP
positive control samples had intra-plate CV of approximately
1.5, and inter-plate relative difference of approximately 15%.
(3) A univariate control TMRM-based Z9 factor for each plate
was calculated to illustrated separation between untreated
samples and positive control in terms of the MMP parameter
of SCRIT vector. In the context of this assay, the computed
Z9 shows attainable separation in terms of TMRM peripheral
integral between two samples. Since the goal of the described
method is to perform semi-supervised classification, rather
than binary separation of two classes (screen), the reported Z9
is interpreted only as a tool to assess system robustness, rather
than an indicator of the overall quality of the assay. Therefore,
the important factor is the reproducibility of the computed Z9,
rather than the absolute value.
(3) KS distances between distributions of TMRM integral from
pooled negative control (untreated) and relevant samples
(wells) were used for the calculation. For each plate, its control








where mp is the mean of KS distances between positive
controls (FCCP treated samples) and the pooled negative
control distribution; mn is the mean of KS distances between
each negative control and the pooled negative control
distribution; sp is the standard deviation of KS distances
between positive controls and the pooled negative control,
and sn is the standard deviation of KS distances between
individual negative controls and the pooled negative control
distribution. The computed control Z9 values for individual
plates were approximately 0.6–0.7. This value was stable and
only minor fluctuations were noted between plates demon-
strating the robustness of the assay conditions.
(4) In order to estimate variability in the secondary assay, we
computed average pair-wise distances between SCRIT
vectors representing repeated measure of FCCP controls.
For the 3-parametric SCRIT vectors constructed with
TMRM peripheral integral, Hoechst33342 intensities and
viability measured at a single drug concentration, the average
distance was 0.15.
Supporting Information
Figure S1 The iCys data processing pipeline.
(TIF)
Figure S2 Effect of Verapamil (V) on TMRM fluores-
cence. HepG2 were cultured on 96-well platesplate for 24 h
before staining. Forty-eight samples (wells) were stained with dye
mix (TMRM. Hoechst33342, and TO-PRO-3) without Verapamil
(top, red border) and 48 samples with the same dye mix containing
20 mM Verapamil (bottom, blue border). A. Representative
images (3006300 mm) of the TMRM channel (left) and merged
fluorescent channels (TMRM - red, Hoechst 33342Hoechst33342
- blue, TO-PRO-3 - magenta) overlaid with the scatter channel
(right) are shown. Note the homogenous staining of cells with
TMRM in the presence of Verapamil and the heterogeneous
staining without it. The arrow points to the morphologically
normal cell showing no TMRM staining. B. TMRM maximal
pixel intensity histograms for all analyzed cells are shown fitted
with a Gaussian function to enable statistical analysis. Blue lines
represent data collected from samples stained without Verapamil,
red lines from those with Verapamil in the dye mix. The Table
below the graph summarizes statistical parameters that describe
the Gaussian distribution.
(TIF)
Figure S3 Differential dose response and SCRIT vector
construction. HepG2 were incubated with different concentra-
tions of compounds (0.001 mM to 100 mM) in glu+ or glu2
conditions, stained with TMRM, Hoechst 33342, and TO-PRO-
3, and analyzed by LSC. A. Graphs show dose responses for KS
values of TMRM IF and VF of TO-PRO-3 for glu+ and glu2
conditions for FCCP (black), ionomycin (red), rotenone (green),
and antimycin A (blue). B. The same graphs are represented as
signature cell responses to induced toxicity (SCRIT) vectors to
demonstrate specific patterns of cell response to different
compounds in different media. Cell viability is rescaled to the
[21, 1] range, where 21 reflects all dead cells and +1 - all alive, to
match the range of KS distances. Four dose response series for
each compound, representing four repeats, are plotted on the
same graph in different colors to demonstrate assay robustness. C.
40-data-point SCRIT vectors that incorporate two parameters, 10
concentrations, and 2 medium conditions (glu+ and glu2) are
represented in a color-coded format. The four repeats of each of
four compounds area plotted in color representing the SCRIT
vectors. Color scale is shown below.
(TIF)
Figure S4 Schematic diagram of primary screening
process. Primary screening was performed using a single high
concentration of the tested compounds (100 mM).). The cells were
exposed to the compounds for 24 h in glu+ and glu2 conditions.
76 compounds were tested on a 96-well plate; 4 FCCP-treated
positive and 4 DMSO-treated negative controls were also included
on the same plate. After 24 h of incubation cells were stained with
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TMRM, Hoechst 33342, and TO-PRO-3 as described in the
Materials and Methods section. Representative fields of view
collected with iCys show three merged channels. The experiment
was performed in duplicate for both glu+ and glu2 conditions.
Seven parameters were further analyzed statistically. SCRIT
vectors demonstrate the seven-parametric response to individual
drugs in glu+ and glu2 conditions (a total of 14 parameters/
compound), where normalized KS distance between control and
compound treated cells using 1 – TMRM peripheral integral 2 –
TMRM maximum pixel, 3 – Hoechst 33342 mean, 4 – Hoechst
33342 integral, 5 – nuclear area, 6 – nuclear circularity, and 7 –
the percentages of viability, from glu+ – (glucose-containing) and
glu2 – (glucose-free) medium. Computation of Euclidian distances
was followed by visual examination of similarities between SCRIT
vectors in order to select responsive compounds. These com-
pounds were kept for a secondary screen. The compounds
showing lack of activity in the primary screen were designated to
group IV – non-toxic or inactive compounds. A change of more
than 20% in any one of seven parameters and/or a change of cell
morphology detected by visual analysis of the transmitted light
image was considered as a marker of response. These compounds
were kept for secondary screening.
(TIF)
Figure S5 Types of anomalous excitation induced by
several compounds. Representative images (5006368 mm
each) for non-treated controls and for cultures treated for 6 h
with 20 mM doxorubicin, 20 mM tamoxifen, and 20 mM campto-
thecin, and for 24 h with 100 mM menadione are shown. Merges
of three fluorescent channels (TMRM - red, Hoechst 33342 - blue,
TO-PRO-3 - magenta) are shown in the left column and
corresponding transmitted light images are shown on the right.
Note the marked decrease of Hoechst 33342 staining after
treatment with doxorubicin and tamoxifen. Doxorubicin and
menadione autofluorescence masks TMRM at high concentra-
tions. Incubation with camptothecin resulted in substantial
autofluorescence background in the Hoechst 33342 channel,
masking nuclear staining and interfering with segmentation.
Lower but considerable Hoechst 33342–channel autofluorescence
was also caused by lapatinib and dasatinib (data not shown).
(TIF)
Methods S1 Additional detailed description are provid-
ed for automated mpHCS for mitochondrial toxicity
protocol, data collection and analysis, TMRM staining
optimization, multiparametric analysis.
(DOCX)
Table S1 A distance matrix between SCRIT vector
responses. Pair-wise distances are the basis for hierarchical
clustering and subsequent multi-dimensional scaling (MDS)
analysis. A small, low pair-wise distance represents a high level
of similarity. Individual samples are shown, including multiple
repeats of each compound. Small values of pair-wise distances
between repeats also demonstrate low variability in the experi-
ment. This is a truncated table provided for demonstration and the
full matrix is available upon request and the values have been
round off.
(XLSX)
Table S2 Compounds used for phenotypic toxicity
characterization. Complete list of compounds used in the
experiment with their alternative names are shown. Primary
screening results with respect to toxicity (‘‘toxicity’’ or ‘‘no
toxicity’’) and incompatibility with automatic fluorescence analysis
(‘‘outlier’’) are shown. Results of secondary screening are shown as
toxicity group number, where I - direct mitochondrial toxins, II -
glu-independent toxins, III - glu-dependent toxins, IV - non-toxic
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